https://www.optimumcomms.com/wp-content/uploads/2022/08/Optimum_Logo_Build.svg
0
0
LRuas
https://www.optimumcomms.com/wp-content/uploads/2022/08/Optimum_Logo_Build.svg
LRuas2023-06-01 07:30:332023-05-31 16:21:15Scarlet Therapeutics: A Bright Spot in Bristol’s Biotech Scene
Scarlet Therapeutics: A Bright Spot in Bristol’s Biotech Scene
Scarlet Therapeutics, a leader in red blood cell-based therapeutics…
International Day of Action for Women’s Health
Over 30 years ago, the International Day of Action…
Could virtual wards be the answer to NHS waiting lists?
As the NHS continues to tackle understaffing and over-demand…
Optimum Hires Senior Journalist Stephen Adams, Former Medical Editor of The Mail on Sunday
London, UK, 15 May 2023 – Optimum Strategic Communications…
Life science leaders give valuable advice on surviving a downturn
The final panel at this year’s Anglonordic Life Science Conference…
In Vivo’s ’30 Rising Leaders’ 2023
Each year, In Vivo spotlights the next wave of entrepreneurs…
ON Helix Conference | 6th July 2023
Optimum is a proud sponsor of ON Helix.
This one-day conference…
This one-day conference…
Sector Moves: April 2023
April moves 2023
Investment firms
Forbion has raised €1.35…
Investment firms
Forbion has raised €1.35…
A profile of Dan Mahony, the UK Government’s Life Sciences Investment Envoy
For this week’s Podcast our in-house IR expert, ex-Fund…
Trends in life science investments – Top take-aways from Anglonordic
The first panel of the day, chaired by Mary Clark, our co-founder…
Destiny Pharma advances strategy against bacteria
Destiny Pharma, one of our longstanding clients, featured…
Breye Therapeutics Strengthens Management Team and Launches Website
Last week, our client Breye Therapeutics announced the appointment…
Link to: Optimum Perspectives Podcast
The Optimum Perspectives Podcast
New episode! Optimum’s in-house IR expert, and ex-Fund Manager Eva Haas interviewed Dan Mahony, Chairman of the BIA, following his appointment as UK Life Sciences Investment Envoy to hear his plans for championing the UK’s Life Sciences industry.
1 May 2023
Optimum’s 15th Annual Healthcare Investor Conference 2023
Now in its 15th year, the conference brings together top executives and business leaders from the life sciences and investment communities.
28 April 2023
Link to: Optimum Hires Senior Journalist Stephen Adams, Former Medical Editor of The Mail on Sunday
Optimum Hires Senior Journalist Stephen Adams, Former Medical Editor of The Mail on Sunday
London, UK, 15 May 2023 – Optimum Strategic Communications (“Optimum”), the specialist life sciences communications consultancy, today announces the appointment of highly-experienced medical journalist, Stephen Adams, as a full-time member of its team.
15 May 2023
Insights
We’d love to hear from you
For more information about Optimum Strategic Communications, please get in touch.
Current public market environment and equity investor views
/in InsightsBiotech is “hot” and M&A deals are likely to be an ongoing feature of the industry
/in InsightsScaling up a Company to $10bn-$20bn
/in Insights